KDM4B and acute myeloid leukemia: Collectively, KDM4B silencing in t(8;21)‐positive AML cell lines impairs the expression of AE‐inducible genes and genes associated with undifferentiated properties, thereby potentially contributing to the observed anti‐proliferative effect.